In vivo magnetic resonance tracking of olfactory ensheathing glia	1
In vivo magnetic resonance	1
olfactory ensheathing glia	40
the rat spinal cord I-Hui Lee	80
a	111
Jeff W.M. Bulte , b Petra Schweinhardt , c Trevor Douglas , d Alexandra Trifunovski , a Christoph Hofstetter , a Lars Olson , a and Christian Spengera	115
Jeff W.M. Bulte	115
b Petra Schweinhardt	131
c Trevor Douglas	152
d Alexandra Trifunovski	169
a Christoph Hofstetter	193
a Lars Olson	216
a	229
Christian Spengera	235
a Department of Neuroscience , Karolinska Institute , Stockholm , Sweden b Department of Radiology and Radiological Sciences , Johns Hopkins Medical Institutions , Baltimore , MD 21287 , USA c Department of Human Anatomy and Genetics , Oxford University , UK d Department of Chemistry and Biochemistry , Montana State University , Bozeman , MT 59717 , USA Abstract Engraftment of olfactory ensheathing cells -LRB- OEC -RRB- , a unique type of glia	254
a Department of Neuroscience	254
a Department	254
Neuroscience	270
Karolinska Institute , Stockholm , Sweden b Department of Radiology and Radiological Sciences	284
Karolinska Institute , Stockholm , Sweden b Department	284
Radiology and Radiological Sciences	340
Johns Hopkins Medical Institutions , Baltimore , MD 21287 , USA c Department of Human Anatomy and Genetics , Oxford University	377
Johns Hopkins Medical Institutions	377
Baltimore	413
MD 21287	424
USA c Department of Human Anatomy and Genetics	434
USA c Department	434
Human Anatomy and Genetics	454
Oxford University	482
UK d Department of Chemistry	501
UK d Department	501
Chemistry	520
Biochemistry , Montana State University , Bozeman , MT 59717 , USA Abstract Engraftment of olfactory ensheathing cells -LRB- OEC -RRB- , a unique type of glia	534
Biochemistry	534
Montana State University	548
Bozeman	574
MT 59717	583
USA Abstract Engraftment of olfactory ensheathing cells -LRB- OEC -RRB-	593
USA Abstract Engraftment	593
olfactory ensheathing cells -LRB- OEC -RRB-	622
olfactory ensheathing cells	622
OEC	651
a unique type of glia	657
a unique type	657
glia	674
olfactory nerve growth	692
life	726
axonal regeneration	757
different types of CNS and PNS injuries	780
different types	780
CNS and PNS injuries	799
a lack of suitable markers of OEC	830
a lack	830
suitable markers of OEC	840
suitable markers	840
OEC	860
studies	877
survival and function of OEC grafts following transplantation	895
survival and function	895
OEC grafts following transplantation	920
OEC grafts	920
transplantation	941
The aim of this study	958
The aim	958
this study	969
the possible usefulness of superparamagnetic iron oxide nanoparticles -LRB- magnetodendrimers -RRB- as a label to allow in vivo tracking of grafted OEC by MR imaging and to determine temporal and spatial migration of OEC in normal and injured rat spinal cords , including the possibility of such cells	995
the possible usefulness	995
superparamagnetic iron oxide nanoparticles	1022
magnetodendrimers	1066
a label to allow in vivo tracking of grafted OEC by MR imaging and to determine temporal and spatial migration of OEC in normal and injured rat spinal cords , including the possibility of such cells	1088
tracking of grafted OEC by MR imaging	1113
tracking	1113
grafted OEC by MR imaging	1125
grafted OEC	1125
MR imaging	1140
temporal and spatial migration of OEC	1168
temporal and spatial migration	1168
OEC	1202
normal and injured rat spinal cords	1209
the possibility of such cells	1256
the possibility	1256
such cells	1275
a complete spinal cord injury zone	1295
We	1331
OEC	1353
vivo by MR imaging for at least 2 months	1384
vivo	1384
MR imaging for at least 2 months	1392
MR imaging	1392
at least 2 months	1407
OEC	1434
normal spinal cord	1462
MRI and histological markers	1493
MRI	1493
histological markers	1501
contrast	1526
OEC	1536
limited migration	1547
transected spinal cord	1568
the transection gap	1618
iron-containing hemorrhage products	1652
interpretation of MR contrast patterns	1699
interpretation	1699
MR contrast patterns	1717
the injured spinal cord	1741
We	1766
MR imaging	1787
noninvasive observation of cell migration dynamics	1812
noninvasive observation	1812
cell migration dynamics	1839
interpretation in severe injuries	1896
interpretation	1896
severe injuries	1914
-LRB- 2 -RRB- OEC migratory and thus regeneration-enhancing ability is	1959
-LRB- 2 -RRB- OEC migratory and thus regeneration-enhancing ability	1959
OEC migratory	1963
thus regeneration-enhancing ability	1981
the glial scar of a transected spinal cord	2049
the glial scar	2049
a transected spinal cord	2067
Introduction Olfactory ensheathing cells -LRB- OEC -RRB-	2094
Introduction Olfactory ensheathing cells	2094
Introduction	2094
Olfactory ensheathing cells	2107
OEC	2136
continuous olfactory nerve fiber growth	2166
the peripheral	2211
the central nervous system throughout adulthood	2231
the central nervous system	2231
adulthood	2269
Barber , 1982 ; Barber and Lindsay , 1982 ; Doucette , 1984 , 1990 ; Doucette et al. , 1983 ; Graziadei and Monti Graziadei , 1980	2280
Barber , 1982 ; Barber and Lindsay , 1982 ; Doucette , 1984 , 1990 ; Doucette et al.	2280
Barber , 1982	2280
Barber	2280
1982	2288
Barber and Lindsay , 1982	2294
Barber and Lindsay	2294
1982	2314
Doucette , 1984 , 1990	2320
Doucette	2320
1984	2330
1990	2336
Doucette et al.	2342
Doucette	2342
et al.	2351
1983 ; Graziadei	2359
1983	2359
Graziadei	2365
Monti Graziadei , 1980	2379
Monti Graziadei	2379
1980	2396
Several studies	2403
a therapeutic potential of OEC grafted to the spinal cord after different types of injuries -LRB- Li et al. , 1997 , 1998 ; Lu et al. , 2001 ; Ramon-Cueto et al. , 1998 , 2000 -RRB-	2437
a therapeutic potential	2437
OEC grafted to the spinal cord after different types of injuries -LRB- Li et al. , 1997 , 1998 ; Lu et al. , 2001 ; Ramon-Cueto et al. , 1998 , 2000 -RRB-	2464
OEC	2464
the spinal cord	2479
different types of injuries -LRB- Li et al. , 1997 , 1998 ; Lu et al. , 2001 ; Ramon-Cueto et al. , 1998 , 2000 -RRB-	2501
different types	2501
injuries -LRB- Li et al. , 1997 , 1998 ; Lu et al. , 2001 ; Ramon-Cueto et al. , 1998 , 2000 -RRB-	2520
injuries	2520
Li et al. , 1997 , 1998 ; Lu et al. , 2001 ; Ramon-Cueto et al. , 1998 , 2000	2530
Li et al.	2530
Li	2530
et al.	2533
1997 , 1998 ; Lu et al. , 2001 ; Ramon-Cueto et al.	2541
1997 , 1998	2541
1997	2541
1998	2547
Lu et al. , 2001	2553
Lu	2553
et al. , 2001	2556
et al.	2556
2001	2564
Ramon-Cueto et al.	2570
Ramon-Cueto	2570
et al.	2582
1998 , 2000	2590
1998	2590
2000	2596
OEC	2603
peripheral-type remyelination	2614
transplantation in partial spinal cord injuries -LRB- Franklin et al. , 1996 ; Imaizumi et al. , 1998 ; Li et al. , 1997 -RRB-	2650
transplantation	2650
partial spinal cord injuries -LRB- Franklin et al. , 1996 ; Imaizumi et al. , 1998 ; Li et al. , 1997 -RRB-	2669
partial spinal cord injuries	2669
Franklin et al. , 1996 ; Imaizumi et al. , 1998 ; Li et al. , 1997	2699
Franklin	2699
et al. , 1996 ; Imaizumi et al. , 1998 ; Li et al. , 1997	2708
et al. , 1996	2708
et al.	2708
1996	2716
Imaizumi et al. , 1998	2722
Imaizumi	2722
et al. , 1998	2731
et al.	2731
1998	2739
Li et al. , 1997	2745
Li	2745
et al. , 1997	2748
et al.	2748
1997	2756
investigations of OEC transplants	2771
investigations	2771
OEC transplants	2789
postmortem histological analysis	2819
p75 immunoreactivity	2883
p75	2913
an exclusively specific marker	2924
OEC	2956
need to be prelabeled before transplantation to be distinguished from , for example	2960
transplantation	2989
example	3035
endogenous p75-positive Schwann cells -LRB- Brook et al. , 1998 -RRB-	3044
endogenous p75-positive Schwann cells	3044
Brook	3083
et al. , 1998	3089
et al.	3089
1998	3097
Fluorescent dyes	3104
cell labeling	3147
extensive migration of OEC	3168
extensive migration	3168
OEC	3191
Boruch et al. , 2001 ; Ramon-Cueto et al. , 1998 , 2000	3214
Boruch et al.	3214
Boruch	3214
et al.	3221
2001 ; Ramon-Cueto et al.	3229
2001	3229
Ramon-Cueto et al.	3235
Ramon-Cueto	3235
et al.	3247
1998 , 2000	3255
1998	3255
2000	3261
redistribution of cell label -LRB- Hoechst 33342 used in these studies -RRB- from transplanted cells to host cells	3268
redistribution of cell label -LRB- Hoechst 33342 used in these studies -RRB-	3268
redistribution of cell label	3268
redistribution	3268
cell label	3286
Hoechst 33342 used in these studies	3298
Hoechst 33342	3298
these studies	3320
transplanted cells to host cells	3340
transplanted cells	3340
host cells	3362
conclusions difficult -LRB- Iwashita et al. , 2000 ; Ruitenberg et al. , 2002 -RRB-	3379
conclusions	3379
Iwashita	3402
et al. , 2000 ; Ruitenberg et al. , 2002	3411
et al.	3411
2000 ; Ruitenberg et al.	3419
2000	3419
Ruitenberg et al.	3425
Ruitenberg	3425
et al.	3436
2002	3444
superparamagnetic nanoparticles	3461
a cell label	3512
transplanted stem cells in vivo for a prolonged period of time -LRB- Bulte et al. , 2001 ; Hoehn et al. , 2002 -RRB-	3536
transplanted stem cells	3536
vivo for a prolonged period of time -LRB- Bulte et al. , 2001 ; Hoehn et al. , 2002 -RRB-	3563
vivo	3563
a prolonged period of time -LRB- Bulte et al. , 2001 ; Hoehn et al. , 2002 -RRB-	3572
a prolonged period	3572
time -LRB- Bulte et al. , 2001 ; Hoehn et al. , 2002 -RRB-	3594
time	3594
Bulte	3600
et al. , 2001 ; Hoehn et al. , 2002	3606
et al.	3606
2001 ; Hoehn et al.	3614
2001	3614
Hoehn et al.	3620
Hoehn	3620
et al.	3626
2002	3634
the small size	3652
the particles	3668
lattice orientation	3700
magnetic hysteresis	3739
rise to reduced MRI signals	3773
rise	3773
reduced MRI signals	3781
T2-weighted images	3804
Noninvasive monitoring of grafted cells in vivo	3824
Noninvasive monitoring	3824
grafted cells in vivo	3850
grafted cells	3850
vivo	3867
us	3881
not only the spatial but also the temporal distribution of cells used in experimental CNS repair strategies	3905
the spatial	3914
the temporal distribution of cells used in experimental CNS repair strategies	3935
the temporal distribution	3935
cells	3964
experimental CNS repair strategies	3978
it	4024
OEC	4071
the terrain of an injured spinal cord	4090
the terrain	4090
an injured spinal cord	4105
nerve pathways	4156
we	4178
magnetodendrimers -LRB- Bulte et al. , 2001 ; Strable et al. , 2001 -RRB- , a type of superparamagnetic nanoparticles ,	4188
magnetodendrimers -LRB- Bulte et al. , 2001 ; Strable et al. , 2001 -RRB-	4188
magnetodendrimers	4188
Bulte	4207
et al. , 2001 ; Strable et al. , 2001	4213
et al.	4213
2001 ; Strable et al.	4221
2001	4221
Strable et al.	4227
Strable	4227
et al.	4235
2001	4243
a type of superparamagnetic nanoparticles	4250
a type	4250
superparamagnetic nanoparticles	4260
a label for in vivo monitoring of grafted cells , and evaluate the migratory ability of OEC in astrocytic scar areas	4296
a label	4296
in vivo monitoring of grafted cells , and evaluate the migratory ability of OEC in astrocytic scar areas	4308
in vivo monitoring of grafted cells	4308
vivo	4311
monitoring	4316
grafted cells	4330
evaluate the migratory ability of OEC in astrocytic scar areas	4349
the migratory ability of OEC	4358
the migratory ability	4358
OEC	4383
astrocytic scar areas	4390
We	4413
tracking of labeled OEC for 2 -- 3 months and migratory ability of OEC within but not across stumps of the transected spinal cord	4431
tracking	4431
OEC for 2 -- 3 months and migratory ability of OEC	4451
OEC for 2	4451
OEC	4451
2	4459
3 months	4461
migratory ability of OEC	4474
migratory ability	4474
OEC	4495
stumps of the transected spinal cord	4521
stumps	4521
the transected spinal cord	4531
Material and methods Cell cultures and labeling Primary OEC cultures	4560
Material and methods Cell	4560
cultures	4586
Primary OEC cultures	4608
olfactory bulbs of adult female Sprague -- Dawley rats -LRB- 150 g body weight , B&K Universal , Sollentuna , Sweden -RRB- as previously described -LRB- Ramon-Cueto and Nieto-Sampedro , 1992 -RRB-	4648
olfactory bulbs	4648
adult female Sprague -- Dawley rats -LRB- 150 g body weight , B&K Universal , Sollentuna , Sweden -RRB- as previously described -LRB- Ramon-Cueto and Nieto-Sampedro , 1992 -RRB-	4667
adult female Sprague -- Dawley rats -LRB- 150 g body weight , B&K Universal , Sollentuna , Sweden -RRB-	4667
adult female Sprague -- Dawley rats	4667
Dawley	4688
150 g body weight , B&K Universal , Sollentuna , Sweden	4701
150 g body weight	4701
B&K Universal	4720
Sollentuna	4735
Sweden	4747
Ramon-Cueto and Nieto-Sampedro	4780
1992	4812
modification of the final purification -LRB- Nash et al. , 2001 -RRB-	4828
modification	4828
the final purification -LRB- Nash et al. , 2001 -RRB-	4844
the final purification	4844
Nash	4868
et al. , 2001	4873
et al.	4873
2001	4881
removal of pia	4903
removal	4903
pia	4914
the nerve fiber , and glomerular layers of olfactory bulbs	4919
the nerve fiber	4919
glomerular layers of olfactory bulbs	4940
glomerular layers	4940
olfactory bulbs	4961
0.1 % trypsin	5020
37jC for 10 min	5036
37jC	5036
10 min	5045
The dissociated cells	5053
The	5053
cells	5069
DMEM / Ham	5106
DMEM	5106
Ham	5112
's	5115
F-12 -LRB- 1:1 mixture , Sigma , St. Louis , MO -RRB- supplemented	5118
F-12	5118
1:1 mixture , Sigma , St. Louis , MO	5124
1:1 mixture	5124
Sigma	5137
St. Louis	5144
MO	5155
10 % fetal bovine serum	5177
uncoated Petri dishes for 54 h	5217
uncoated Petri dishes	5217
54 h	5243
OEC	5249
supernatant	5273
poly-L-lysine-coated culture flasks	5300
confluency in 10 -- 12 days	5360
confluency in 10	5360
confluency	5360
10	5374
12 days	5377
the day before transplantation	5389
the day	5389
transplantation	5404
OEC	5421
magnetodendrimers -LRB- MD-100 , 25 Ag Fe/ml , 20 nm in diameter -RRB- -LRB- Bulte et al. , 2001 ; Strable et al. , 2001 -RRB-	5443
magnetodendrimers -LRB- MD-100 , 25 Ag Fe/ml , 20 nm in diameter -RRB-	5443
magnetodendrimers	5443
MD-100 , 25 Ag Fe/ml	5462
MD-100	5462
25 Ag Fe/ml	5470
20 nm in diameter	5483
20 nm	5483
diameter	5492
Bulte	5503
et al. , 2001 ; Strable et al. , 2001	5509
et al.	5509
2001 ; Strable et al.	5517
2001	5517
Strable et al.	5523
Strable	5523
et al.	5531
2001	5539
Cells	5546
37jC for 24 h	5570
37jC	5570
24 h	5579
three times	5592
Hank 's balanced salt solution	5609
Hank 's	5609
0.25 % trypsin	5659
They	5674
glass chamber slides for histological evaluation	5708
glass chamber slides	5708
histological evaluation	5733
trypan blue	5773
105 cells/Al suspensions in DMEM/Ham 's	5812
105 cells/Al suspensions	5812
DMEM/Ham 's	5840
F-12 for transplantation	5851
F-12	5851
transplantation	5860
Surgical procedures Adult female Sprague -- Dawley rats -LRB- 250 -- 300 g body weight -RRB-	5877
Surgical procedures Adult female Sprague -- Dawley rats	5877
Surgical procedures	5877
Adult female Sprague -- Dawley rats	5897
Dawley	5918
250 -- 300 g body weight	5931
250	5931
300 g body weight	5935
transection of the spinal cord	5981
transection	5981
the spinal cord	5996
laminectomy of T8	6019
laminectomy	6019
T8	6034
the dura	6038
the spinal cord	6063
microscissors	6090
The stumps	6105
complete transection	6145
Animals	6167
two treatment groups : one injection of 4 Al labeled OEC at the midline of either stump 1 mm from the transection site -LRB- n = 9 for rostral stump injection ; n = 8 for caudal stump injection -RRB-	6201
two treatment groups	6201
one injection of 4 Al labeled OEC at the midline of either stump 1 mm from the transection site -LRB- n = 9 for rostral stump injection ; n = 8 for caudal stump injection -RRB-	6223
one injection	6223
4 Al labeled OEC at the midline of either stump 1 mm from the transection site -LRB- n = 9 for rostral stump injection ; n = 8 for caudal stump injection -RRB-	6240
4 Al	6240
OEC	6253
the midline of either stump 1 mm from the transection site	6260
the midline	6260
stump 1 mm	6282
the transection site	6298
n = 9 for rostral stump injection ; n = 8	6320
n	6320
= 9 for rostral stump injection ; n = 8	6322
= 9 for rostral stump injection	6322
= 9	6322
rostral stump injection	6330
n = 8	6355
n	6355
8	6359
caudal stump injection	6365
A total of 4 x 105 OECs	6390
A total	6390
4 x 105 OECs	6401
4	6401
105 OECs	6405
each rat	6429
The cell suspension	6439
a 10 Al Hamilton syringe at a speed of 1 Al/min -LRB- Ultra - MicroPump-II , Sarasota , FL -RRB- via polyethylene tubing and a glass capillary -LRB- outer diameter 100 Am -RRB- mounted on a stereotactic device	6476
a 10 Al Hamilton syringe at a speed of 1 Al/min -LRB- Ultra - MicroPump-II , Sarasota , FL -RRB- via polyethylene tubing and a glass capillary	6476
a 10 Al Hamilton syringe	6476
a speed of 1 Al/min -LRB- Ultra - MicroPump-II , Sarasota , FL -RRB- via polyethylene tubing and a glass capillary	6504
a speed	6504
1 Al/min -LRB- Ultra - MicroPump-II , Sarasota , FL -RRB- via polyethylene tubing and a glass capillary	6515
1 Al/min -LRB- Ultra - MicroPump-II , Sarasota , FL -RRB-	6515
Ultra	6525
MicroPump-II , Sarasota , FL	6532
MicroPump-II	6532
Sarasota	6546
FL	6556
polyethylene tubing and a glass capillary	6564
polyethylene tubing	6564
a glass capillary	6588
outer diameter 100 Am	6607
outer diameter	6607
100	6622
a stereotactic device	6641
Each injection	6664
four depths of 1.75 , 1.25 , 1 , and 0.5 mm	6696
four depths	6696
1.75 , 1.25 , 1 , and 0.5 mm	6711
1.75	6711
1.25	6717
1	6723
0.5 mm	6730
equal amount -LRB- corresponding to ventral funiculus , grey commissure , dorsal corticospinal tract , gracile fasciculus -RRB-	6740
ventral funiculus , grey commissure , dorsal corticospinal tract , gracile fasciculus	6771
ventral funiculus	6771
grey commissure	6790
dorsal corticospinal tract	6807
gracile fasciculus	6835
Control groups	6856
cord transection	6880
medium injection -LRB- n = 6 -RRB-	6902
medium injection	6902
n	6920
6	6924
unlabeled OEC -LRB- n = 2 for either rostral or caudal stump grafting -RRB- ; normal spinal cords with labeled live -LRB- n = 8 -RRB- , labeled dead -LRB- n = 4 -RRB- , and unlabeled live OEC transplant -LRB- n = 4 -RRB-	6933
unlabeled OEC	6933
n = 2 for either rostral or caudal stump grafting	6948
n = 2	6948
n	6948
2	6952
either rostral or caudal stump grafting	6958
rostral	6965
caudal stump grafting	6976
normal spinal cords with labeled live -LRB- n = 8 -RRB-	7000
normal spinal cords	7000
n = 8	7039
n	7039
= 8	7041
dead -LRB- n = 4 -RRB- , and unlabeled live OEC transplant -LRB- n = 4 -RRB-	7055
dead -LRB- n = 4 -RRB- , and unlabeled live OEC transplant	7055
n = 4	7061
n	7061
= 4	7063
n	7104
4	7108
Experiments	7112
the Animal Research Committee of Stockholm	7141
the Animal Research Committee	7141
Stockholm	7174
Behavioral testing All cord-transected rats , including medium-injected and OEC-transplanted ones ,	7185
Behavioral testing All cord-transected rats	7185
Behavioral testing	7185
All cord-transected rats	7204
medium-injected and OEC-transplanted ones	7240
the open field walking according to the BBB rating scale -LRB- Basso et al. , 1995 -RRB- every 2 weeks up to 8 weeks post transplantation	7299
the open field	7299
the BBB rating scale -LRB- Basso et al. , 1995 -RRB- every 2 weeks up to 8 weeks post transplantation	7335
the BBB rating scale -LRB- Basso et al. , 1995 -RRB-	7335
the BBB rating scale	7335
Basso	7357
et al. , 1995	7363
et al.	7363
1995	7371
every 2 weeks up to 8 weeks post transplantation	7377
2 weeks up to 8 weeks	7383
2 weeks	7383
MRI MRI scans	7427
earlier -LRB- Fraidakis et al. , 1998 -RRB-	7468
earlier	7468
Fraidakis	7477
et al. , 1998	7487
et al.	7487
1998	7495
a spectrometer with a 4.7-T field strength magnet and a 40-cm horizontal	7511
a spectrometer	7511
a 4.7-T field strength magnet and a 40-cm horizontal	7531
a 4.7-T field strength magnet	7531
a 40-cm horizontal	7565
diameter -LRB- Bruker Biospec Avance 47/40 , Bruker , Karlsruhe , Germany -RRB-	7589
diameter	7589
Bruker Biospec Avance 47/40 , Bruker , Karlsruhe , Germany	7599
Bruker Biospec Avance 47/40	7599
Bruker	7628
Karlsruhe	7636
Germany	7647
A commercially available doubletuned 1H/31P 40-mm surface coil with a planar circular detection area	7670
A commercially available doubletuned 1H/31P 40-mm surface coil	7670
a planar circular detection area	7738
MR imaging of labeled OEC suspensions	7790
MR imaging	7790
labeled OEC suspensions	7804
a series of different concentrations of cells -LRB- 102 , 103 , 2.5 x 103 , 5 x 103 , 104 , 2 x 104 , and 5 x 104 cells -RRB-	7829
a series	7829
different concentrations of cells -LRB- 102 , 103 , 2.5 x 103 , 5 x 103 , 104 , 2 x 104 , and 5 x 104 cells -RRB-	7841
different concentrations	7841
cells -LRB- 102 , 103 , 2.5 x 103 , 5 x 103 , 104 , 2 x 104 , and 5 x 104 cells -RRB-	7869
cells	7869
102 , 103	7876
102	7876
103	7881
2.5 x 103 , 5 x 103 , 104 , 2 x 104 , and 5 x 104 cells	7886
2.5 x 103	7886
2.5 x	7886
103	7892
5 x 103	7897
5 x	7897
103	7901
104	7906
2 x 104 , and 5 x 104 cells	7911
2 x 104	7911
2	7911
104	7915
5 x 104 cells	7924
5	7924
104 cells	7928
0.5 % agarose gel	7957
The agarose plate was imaged using gradient echo and spin	7975
The agarose plate	7975
gradient	8010
pulse sequences	8038
These images	8055
a field of view of 10 x 10 cm and a 1-mm slice thickness	8087
a field	8087
view of 10 x 10 cm and a 1-mm slice thickness	8098
view	8098
10 x 10 cm and a 1-mm slice thickness	8106
10	8106
10 cm and a 1-mm slice thickness	8111
10 cm	8111
a 1-mm slice thickness	8121
1	8148
8 , and 12 weeks postgrafting -LRB- only control normal spinal cords at the latest time point -RRB- , grafted rats were fixed onto the MRI rig with a tooth holder in supine position ,	8151
8	8151
12 weeks postgrafting -LRB- only control normal spinal cords at the latest time point -RRB-	8158
12 weeks postgrafting	8158
12 weeks	8158
only control normal spinal cords at the latest time point	8181
only control normal spinal cords	8181
the latest time point	8217
rats	8249
the MRI rig	8270
a tooth holder in supine position	8287
a tooth holder	8287
supine position	8305
the tail	8342
the rig with adhesive tape	8354
the rig	8354
adhesive tape	8367
sustained	8386
Styrofoam	8412
Anesthesia	8423
isoflurane -LRB- 1 -- 1.2 % -RRB- administered through a mask adapted to the mouthpiece of the rig	8454
isoflurane	8454
1 -- 1.2 %	8466
1	8466
1.2 %	8468
a mask adapted to the mouthpiece of the rig	8495
a mask	8495
the mouthpiece of the rig	8513
the mouthpiece	8513
the rig	8531
Body temperature	8540
the range of 36.5	8573
the range	8573
36.5	8586
37.5 jC	8591
a temperature-controlled air stream	8604
the body of the rat	8647
the body	8647
the rat	8659
The main sequence applied for spinal cord imaging	8668
The main sequence	8668
spinal cord imaging	8698
a Bruker implementation of rapid acquisition with relaxation enhancement -LRB- RARE -RRB- imaging -LRB- Hennig et al. , 1986 -RRB-	8722
a Bruker implementation	8722
rapid acquisition with relaxation enhancement -LRB- RARE -RRB- imaging -LRB- Hennig et al. , 1986 -RRB-	8749
rapid acquisition	8749
relaxation enhancement -LRB- RARE -RRB- imaging -LRB- Hennig et al. , 1986 -RRB-	8772
relaxation enhancement -LRB- RARE -RRB- imaging	8772
relaxation enhancement -LRB- RARE -RRB-	8772
relaxation enhancement	8772
RARE	8796
Hennig	8811
et al. , 1986	8818
et al.	8818
1986	8826
T2-weighted images	8837
the following parameters	8857
RARE factor 8 , TR 2500 ms , average TE from the RARE echo train 61 ms , field of view 6 x 6 cm , matrix 512 x 512 pixels , slice thickness 1 mm	8893
RARE factor 8	8893
RARE factor	8893
8	8905
TR 2500 ms , average TE from the RARE echo train 61 ms , field of view 6 x 6 cm , matrix 512 x 512 pixels , slice thickness 1 mm	8908
TR	8908
2500 ms , average TE from the RARE	8911
2500 ms	8911
average TE from the RARE	8920
average TE	8920
the RARE	8936
train 61 ms , field of view 6 x 6 cm , matrix 512 x 512 pixels , slice thickness 1 mm	8950
train 61 ms	8950
train	8950
61 ms	8956
field of view 6 x 6 cm	8963
field	8963
view 6 x 6 cm	8972
view 6	8972
6 cm	8981
matrix 512 x 512 pixels	8987
matrix 512	8987
512 pixels	9000
slice thickness 1 mm	9012
slice thickness	9012
1 mm	9028
Histological evaluation Histological evaluation	9034
Histological evaluation	9034
Histological evaluation	9058
the endpoint of the experiment in all rats	9099
the endpoint	9099
the experiment in all rats	9115
the experiment	9115
all rats	9133
behavioral tests and MR imaging	9148
behavioral tests	9148
MR imaging	9169
Three additional rats per treatment group	9181
Three additional rats	9181
treatment group	9207
1 week	9239
histology	9265
Rats	9276
physiological saline containing 10 units/ml heparin followed by 4 % paraformaldehyde in 0.1 M icecold phosphate buffer , pH 7.4	9300
physiological saline	9300
10 units/ml heparin followed by 4 % paraformaldehyde in 0.1 M	9332
10 units/ml	9332
heparin	9344
4 % paraformaldehyde in 0.1 M	9364
4 % paraformaldehyde	9364
0.1 M	9387
icecold phosphate buffer , pH 7.4	9393
icecold phosphate buffer	9393
pH 7.4	9419
The spinal cords	9427
1 h at room temperature	9474
1 h	9474
room temperature	9481
10 % sucrose for 48 h	9511
10 % sucrose	9511
48 h	9527
4jC	9535
A 3-cm-long spinal segment centered at the injection/transection site	9540
A 3-cm-long spinal segment	9540
the injection/transection site	9579
14	9640
Am thickness on a cryostat	9643
a cryostat	9659
immunohistochemistry	9675
the sections	9697
primary antibodies	9730
4jC overnight	9752
Antisera	9767
rabbit	9786
glial fibrillary astrocytic protein -LRB- GFAP , Sigma , 1:100 -RRB- , neurofilament -LRB- Dahl , Chesnut Hill , MA , 1:400 -RRB- , and mouse monoclonal antibodies against the low-affinity neurotrophin receptor p75 -LRB- Abcam , Cambridge , UK , 1:500 -RRB-	9801
glial fibrillary astrocytic protein -LRB- GFAP , Sigma , 1:100 -RRB-	9801
glial fibrillary astrocytic protein	9801
GFAP	9838
Sigma	9844
1:100	9851
neurofilament -LRB- Dahl , Chesnut Hill , MA , 1:400 -RRB-	9859
neurofilament	9859
Dahl , Chesnut Hill , MA , 1:400	9874
Dahl	9874
Chesnut Hill	9880
MA	9894
1:400	9898
mouse monoclonal antibodies against the low-affinity neurotrophin receptor p75 -LRB- Abcam , Cambridge , UK , 1:500 -RRB-	9910
mouse monoclonal antibodies	9910
the low-affinity neurotrophin receptor p75 -LRB- Abcam , Cambridge , UK , 1:500 -RRB-	9946
the low-affinity neurotrophin receptor p75	9946
Abcam	9990
Cambridge , UK	9997
1:500	10012
ED1 -LRB- Serotec , Raleigh , NC , 1:200 -RRB-	10020
ED1	10020
Serotec	10025
Raleigh , NC	10034
1:200	10047
0.3 % Triton X , 0.1 M PBS	10067
0.3 % Triton X	10067
0.1 M PBS	10082
three times	10107
the sections	10120
secondary antibodies conjugated with Cy2 or Cy3 -LRB- Jackson ImmunoResearch , West Grove , PA -RRB- for 1 h at room temperature	10153
secondary antibodies	10153
Cy2 or Cy3 -LRB- Jackson ImmunoResearch , West Grove , PA -RRB- for 1 h	10190
Cy2 or Cy3 -LRB- Jackson ImmunoResearch , West Grove , PA -RRB-	10190
Cy2 or Cy3	10190
Jackson ImmunoResearch	10202
West Grove	10226
PA	10238
1 h	10246
room temperature	10253
The slides	10271
anti-fading agent	10314
analysis	10354
epifluorescence and confocal -LRB- Radiance 2100 , Biorad -RRB- microscopy	10366
epifluorescence	10366
confocal -LRB- Radiance 2100 , Biorad -RRB- microscopy	10386
Radiance 2100	10396
Biorad	10411
ferric iron	10435
Prussian blue	10448
diaminobenzidine -LRB- DAB -RRB- enhancement was used	10473
diaminobenzidine -LRB- DAB -RRB-	10473
diaminobenzidine	10473
DAB	10491
enhancement	10496
Slides	10518
2 % potassium ferrocyanide -LRB- Perls ' reagent -RRB- in 6 % HCl for 30 min	10545
2 % potassium ferrocyanide -LRB- Perls ' reagent -RRB-	10545
2 % potassium ferrocyanide	10545
Perls ' reagent	10572
6 % HCl for 30 min	10591
6 % HCl	10591
30 min	10602
H2O2 activated DAB -LRB- Sigma -RRB- for 15 min	10635
H2O2 activated DAB -LRB- Sigma -RRB-	10635
H2O2 activated DAB	10635
Sigma	10655
15 min	10666
Statistical analysis Behavioral BBB scores were compared using the Kruskal -- Wallis test for nonparametric data .	10674
Statistical analysis Behavioral BBB scores were compared using the Kruskal	10674
Statistical analysis	10674
Behavioral BBB scores	10695
the Kruskal	10737
Wallis test for nonparametric data	10750
Wallis test	10750
nonparametric data	10766
Pearson correlations -LRB- correlation coefficient , r -RRB- between migration distances of OEC transplants determined using MRI , DAB-enhanced Prussian blue staining , and anti-p75 staining	10786
Pearson correlations -LRB- correlation coefficient , r -RRB-	10786
Pearson correlations	10786
correlation coefficient , r	10808
correlation coefficient	10808
r	10833
migration distances of OEC transplants determined using MRI , DAB-enhanced Prussian blue staining , and anti-p75 staining	10844
migration distances	10844
OEC transplants determined using MRI , DAB-enhanced Prussian blue staining , and anti-p75 staining	10867
OEC transplants	10867
MRI , DAB-enhanced Prussian blue staining , and anti-p75 staining	10900
MRI	10900
DAB-enhanced Prussian blue staining	10905
anti-p75 staining	10946
SPSS software	10986
Results	11002
1	11015
Magnetic particle labeling of OEC .	11018
Magnetic particle labeling	11018
OEC	11048
-LRB- A -RRB- p75-immunoreactive OEC in culture before labeling with magnetic nanoparticles -LRB- B -RRB- MR image of agar plate with deposits of labeled OEC , seen from above -LRB- top -RRB- and from the side -LRB- bottom , slice through one row of OEC deposits -RRB- .	11053
-LRB- A -RRB- p75-immunoreactive OEC	11053
A	11054
culture before labeling with magnetic nanoparticles -LRB- B -RRB- MR image of agar plate with deposits of labeled OEC	11083
culture	11083
magnetic nanoparticles -LRB- B -RRB-	11112
magnetic nanoparticles	11112
B	11136
MR image of agar plate with deposits of labeled OEC	11139
MR image	11139
agar plate with deposits of labeled OEC	11151
agar plate	11151
deposits of labeled OEC	11167
deposits	11167
labeled OEC	11179
above -LRB- top -RRB-	11202
above	11202
top	11209
the side	11223
bottom , slice	11233
bottom	11233
slice	11241
one row of OEC deposits	11255
one row	11255
OEC deposits	11266
OEC	11289
T2-weighted hypointense signals	11302
The intensity is cell number -LRB- listed below -RRB-	11335
The intensity	11335
cell number -LRB- listed below -RRB-	11352
cell number	11352
Arrowhead	11388
distinct contrast	11408
a cell cluster with a minimum of 5 103 labeled cells especially when viewed from the side	11430
a cell cluster	11430
a minimum of 5 103	11450
a minimum	11450
5 103	11463
cells	11479
the side	11513
-LRB- C -RRB- Non-enhanced and -LRB- D -RRB- DAB-enhanced Prussian blue stains of the same labeled OEC culture under phase contrast microscopy .	11523
-LRB- C -RRB- Non-enhanced and -LRB- D -RRB- DAB-enhanced Prussian blue stains of the same	11523
-LRB- C -RRB-	11523
Non-enhanced and -LRB- D -RRB- DAB-enhanced Prussian blue stains of the same	11527
Non-enhanced	11527
D	11545
DAB-enhanced Prussian blue stains of the same	11548
DAB-enhanced Prussian blue stains	11548
the same	11585
OEC culture	11602
phase contrast microscopy	11620
high labeling efficacy -LRB- > 99 % -RRB-	11652
high labeling efficacy	11652
> 99 %	11676
>	11676
99 %	11677
24 h incubation	11688
MD-100	11709
Iron-containing vesicles	11717
cytoplasm	11757
the nucleus	11778
Scale bars	11791
50 µm -LRB- A -RRB- , 100 µm -LRB- D -RRB-	11804
50 µm -LRB- A -RRB-	11804
A	11811
100 µm -LRB- D -RRB-	11815
D	11823
Fig. 2 .	11828
Fig.	11828
2	11833
In vivo tracking -LRB- A -- C -RRB- of MD-100-labeled OEC and correlation with histology -LRB- D , E -RRB- in normal spinal cord .	11836
In vivo tracking	11836
A -- C	11854
A	11854
C	11856
MD-100-labeled OEC and correlation	11862
histology -LRB- D , E -RRB- in normal spinal cord	11902
histology -LRB- D , E -RRB-	11902
histology	11902
D , E	11913
D	11913
E	11916
normal spinal cord	11922
-LRB- A -RRB- Long extension of hypointensity area -LRB- 9 mm long -RRB- from the injection site -LRB- arrow -RRB- in a rat 8 weeks following transplantation of	11942
-LRB- A -RRB- Long extension	11942
A	11943
hypointensity area -LRB- 9 mm long -RRB- from the injection site -LRB- arrow -RRB- in a rat 8 weeks	11964
hypointensity area -LRB- 9 mm long -RRB-	11964
hypointensity area	11964
9 mm	11984
the injection site -LRB- arrow -RRB-	12000
the injection site	12000
arrow	12020
a rat	12030
8 weeks	12036
transplantation of	12054
transplantation	12054
viable OEC -LRB- left , horizontal slice ; right , sequential transverse slices , 1-mm slices , 1-mm slice interval -RRB-	12081
viable OEC	12081
left , horizontal slice ; right , sequential transverse slices , 1-mm slices , 1-mm slice interval	12093
left	12093
horizontal slice ; right , sequential transverse slices , 1-mm slices	12099
horizontal slice ; right , sequential transverse slices ,	12099
horizontal slice ; right	12099
horizontal slice	12099
sequential transverse slices	12124
1-mm slices	12154
1-mm slice interval	12167
Levels of transverse slices	12189
Levels	12189
transverse slices	12199
the horizontal image	12234
r , rostral ; v , ventral .	12256
r , rostral	12256
r	12256
rostral	12259
v , ventral	12268
v	12268
ventral	12271
-LRB- B -RRB- Control MR images of a rat spinal cord 4 weeks following transplantation of labeled dead OEC .	12280
-LRB- B -RRB- Control MR images of a rat spinal cord 4 weeks following transplantation of	12280
Control MR images	12284
a rat spinal cord 4 weeks following transplantation of	12305
a rat spinal cord	12305
4 weeks	12323
transplantation of	12341
transplantation	12341
dead OEC	12368
localized dark contrast -LRB- arrow -RRB-	12383
localized dark contrast	12383
arrow	12408
2 mm	12422
-LRB- C -RRB- Control MR images of a rat spinal cord 1 week following transplantation of unlabeled live OEC .	12428
-LRB- C -RRB- Control MR images of a rat spinal cord 1 week following transplantation of unlabeled live OEC	12428
Control MR images	12432
a rat spinal cord 1 week following transplantation of unlabeled live OEC	12453
a rat spinal cord	12453
1 week	12471
transplantation of unlabeled live OEC	12488
transplantation	12488
unlabeled live OEC	12507
Arrowhead	12527
a faint hypointense spot	12543
the injection site	12571
mild hemorrhage	12607
D , E	12625
D	12625
E	12628
Longitudinal sections of the same rat spinal cord	12631
Longitudinal sections	12631
the same rat spinal cord	12656
in A	12687
both Prussian blue	12706
Prussian blue	12711
Prussian	12711
DAB enhancement and p75	12736
immunoreactivity	12760
the area of MR contrast	12783
the area	12783
MR contrast	12795
OEC	12808
spinal cord tracts	12832
8 mm	12857
-LRB- Inset -RRB- A spindle-shaped cell containing dark iron vesicles .	12863
-LRB- Inset -RRB- A spindle-shaped cell	12863
-LRB- Inset -RRB-	12863
A spindle-shaped cell	12871
dark iron vesicles	12904
Scale bars	12924
= 0.25 cm -LRB- A -- C -RRB- , 500 Am -LRB- D , E -RRB- , 50 Am	12935
= 0.25 cm -LRB- A -- C -RRB-	12935
= 0.25 cm	12935
0.25	12937
A -- C	12946
A	12946
C	12949
500 Am -LRB- D , E -RRB-	12953
500	12953
D , E	12961
D	12961
E	12964
50	12968
D , high magnification	12975
D	12975
high magnification	12978
Fig. 3 .	13000
Fig.	13000
3	13005
Limited OEC migration in the transected spinal cord .	13008
Limited OEC migration	13008
the transected spinal cord	13033
-LRB- A -RRB- In vivo MR images of a lesioned rat 8 weeks after transplantation into the caudal stump -LRB- left , horizontal slice ; right , sequential transverse slices , 1-mm slices , 2-mm slice interval -RRB- .	13061
-LRB- A -RRB-	13061
In vivo MR images	13065
In vivo MR	13065
images	13076
a lesioned rat 8 weeks after transplantation into the caudal stump -LRB- left , horizontal slice ; right , sequential transverse slices , 1-mm slices , 2-mm slice interval -RRB-	13086
a lesioned rat	13086
8 weeks	13101
transplantation into the caudal stump -LRB- left , horizontal slice ; right , sequential transverse slices , 1-mm slices , 2-mm slice interval -RRB-	13115
transplantation	13115
the caudal stump -LRB- left , horizontal slice ; right , sequential transverse slices , 1-mm slices , 2-mm slice interval -RRB-	13136
the caudal stump	13136
left , horizontal slice ; right , sequential transverse slices , 1-mm slices , 2-mm slice interval	13154
left	13154
horizontal slice ; right , sequential transverse slices , 1-mm slices	13160
horizontal slice ; right , sequential transverse slices ,	13160
horizontal slice ; right	13160
horizontal slice	13160
sequential transverse slices	13185
1-mm slices	13215
2-mm slice interval	13228
Arrows	13250
needle track	13266
Note extended hypointense contrast in	13280
Note	13280
hypointense contrast	13294
22 mm	13336
Yellow lines	13348
the relative sites of the transverse slices	13370
the relative sites	13370
the transverse slices	13392
r , rostral ; v , ventral .	13415
r , rostral	13415
r	13415
rostral	13418
v , ventral	13427
v	13427
ventral	13430
-LRB- B -RRB- Horizontal section of the same rat spinal cord labeled with DAB-enhanced Prussian blue	13439
-LRB- B -RRB- Horizontal section	13439
B	13440
the same rat spinal cord labeled with DAB-enhanced Prussian blue	13465
the same rat spinal cord	13465
DAB-enhanced Prussian blue	13503
DAB-enhanced	13503
iron distributed in both stumps	13544
iron	13544
stumps	13569
MR contrast in the grafted stump	13581
MR contrast	13581
the grafted stump	13596
DAB-enhanced Prussian blue stain -LRB- Pearson correlation coefficient 0.628 , * P < 0.05 -RRB-	13643
DAB-enhanced Prussian blue stain	13643
DAB-enhanced	13643
Prussian blue	13656
Pearson correlation coefficient	13677
0.628 , * P < 0.05	13709
0.628	13709
P <	13717
P	13717
<	13719
0.05	13721
D	13735
there	13738
no such correlation in the non-grafted stump	13748
no such correlation	13748
the non-grafted stump	13771
Red triangle , rostral stump grafting ; green square , caudal stump grafting .	13794
Red triangle , rostral stump grafting	13794
Red triangle	13794
rostral stump grafting	13808
green square , caudal stump grafting	13832
green square	13832
caudal stump grafting	13846
-LRB- E -RRB- Neurofilament-positive fibers -LRB- green -RRB-	13869
-LRB- E -RRB- Neurofilament-positive fibers	13869
-LRB- E -RRB-	13869
Neurofilament-positive fibers	13873
grafted OEC -LRB- red -RRB- along the long axis of the spinal cord	13928
grafted OEC -LRB- red -RRB-	13928
grafted OEC	13928
red	13941
the long axis of the spinal cord	13952
the long axis	13952
the spinal cord	13969
-LRB- F -RRB- OEC graft -LRB- red -RRB-	13986
-LRB- F -RRB- OEC graft	13986
-LRB- F -RRB-	13986
OEC graft	13990
red	14001
glial scar	14018
the transection site	14032
-LRB- G -RRB- Summary diagrams depicting temporal and spatial distribution of OEC grafts and iron particles .	14054
-LRB- G -RRB- Summary diagrams	14054
-LRB- G -RRB-	14054
Summary diagrams	14058
temporal and spatial distribution of OEC grafts and iron particles	14085
temporal and spatial distribution	14085
OEC grafts and iron particles	14122
Needles	14153
injection sites	14170
normal spinal cord	14190
p75 immunoreactivity -LRB- red -RRB-	14210
p75 immunoreactivity	14210
red	14232
DAB-enhanced Prussian blue stain -LRB- black -RRB- and spreads cranially and caudally with time	14255
DAB-enhanced Prussian blue	14255
time	14336
transected spinal cord	14354
there	14378
a mismatch between the two markers	14387
a mismatch	14387
the two markers	14406
p75 immunoreactivity	14423
the stump of grafting without significant spreading between 1 and 8 weeks postgrafting	14464
the stump	14464
significant spreading between 1 and 8 weeks postgrafting	14494
significant spreading	14494
1 and 8 weeks postgrafting	14524
1 and 8 weeks	14524
contrast	14555
DAB-enhanced Prussian blue	14565
DAB-enhanced	14565
spreads along central white matter tracts in both stumps as early as 1 week after transplantation , regardless of which stump has been grafted	14598
spreads	14598
central white matter tracts in both stumps as early as 1 week after transplantation , regardless of which stump has been grafted	14612
central white matter tracts	14612
both stumps as early as 1 week after transplantation	14643
both stumps	14643
early as 1 week after transplantation	14658
early	14658
1 week after transplantation	14667
1 week	14667
transplantation	14680
stump	14717
The results	14741
extensive hemorrhage	14766
rise	14793
T2-weighted hypointensity	14801
Prussian blue deposits	14831
iron-containing nanoparticles	14877
Scale bars = 0.25 cm -LRB- A -RRB- , 500	14908
Scale bars = 0.25 cm -LRB- A -RRB-	14908
Scale bars	14908
= 0.25 cm -LRB- A -RRB-	14919
= 0.25 cm	14919
0.25	14921
A	14930
500	14934
-LRB- B -RRB- , 10 µm -LRB- E -RRB- , 500 µm -LRB- F -RRB-	14941
-LRB- B -RRB-	14941
10 µm -LRB- E -RRB- , 500 µm -LRB- F -RRB-	14946
10 µm	14946
E	14953
500 µm -LRB- F -RRB-	14957
F	14965
Magnetic labeling of OEC	14970
Magnetic labeling	14970
OEC	14991
our primary cultures	14998
50 -- 70 % of the cells	15020
50 -- 70 %	15020
50	15020
the cells	15030
OEC	15045
p75 immunoreactivity -LRB- Fig. 1A -RRB-	15065
p75 immunoreactivity	15065
Fig. 1A	15087
Astrocytes and fibroblasts	15097
30 -- 50 %	15148
30	15148
24 h incubation with MD-100 nanoparticles	15162
24 h incubation	15162
MD-100 nanoparticles	15183
more than 99 % of the cells	15205
more than 99 %	15205
the cells	15222
positive Prussian blue staining -LRB- with or without DAB enhancement -RRB-	15239
positive Prussian blue staining	15239
DAB enhancement	15288
Prussian blue staining with DAB enhancement	15306
Prussian blue staining	15306
DAB enhancement	15334
iron-containing vesicles	15363
the cytoplasm	15391
the nucleus -LRB- Figs. 1C -- D -RRB-	15417
the nucleus	15417
Figs. 1C -- D	15430
Figs. 1C	15430
D	15439
The cell morphology	15443
any signs of degeneration	15479
any signs	15479
degeneration	15492
trypan blue staining	15510
decreased viability	15547
unlabeled cells	15581
The labeled cells	15598
low T2-weighted signals	15626
the intensity	15655
thenumber of labeled cells	15684
thenumber	15684
labeled cells	15697
A cell cluster with a minimum of 5	15712
A cell cluster	15712
a minimum of 5	15732
a minimum	15732
5	15745
103 labeled cells led to distinct MRI contrast allowing detection -LRB- Fig. 1B -RRB-	15749
103 labeled cells led to distinct MRI contrast allowing detection	15749
103	15749
cells	15761
distinct MRI contrast	15774
detection	15805
Fig. 1B	15816
In vivo MR tracking and correlation	15826
In vivo MR tracking	15826
correlation	15850
histology in the normal spinal cord	15867
histology	15867
the normal spinal cord	15880
The labeled OEC	15903
MR imaging in normal spinal cords 2 months	15943
MR imaging	15943
normal spinal cords	15957
2 months	15977
A `` positive '' MR signal	16000
a distinctive dark area in T2	16040
a distinctive dark area	16040
T2	16067
weighted images	16071
at least three contiguous pixels	16101
The MR contrast	16135
the dorsal column at 1 week postgrafting -LRB- maximal extension found : 8 mm -RRB-	16180
the dorsal column	16180
1 week postgrafting -LRB- maximal extension found : 8 mm -RRB-	16201
1 week postgrafting	16201
maximal extension found : 8 mm	16222
maximal extension	16222
8 mm	16247
8	16247
mm	16249
Maximal migration	16254
4 weeks -LRB- maximal extension found : 9 mm -RRB- , and such signals were maintained up to 2 -- 3 months -LRB- Fig. 2A -RRB-	16297
4 weeks -LRB- maximal extension found : 9 mm -RRB-	16297
4 weeks	16297
maximal extension found : 9 mm	16306
maximal extension found	16306
maximal extension	16306
9 mm	16331
9	16331
mm	16333
such signals were maintained up to 2 -- 3 months -LRB- Fig. 2A -RRB-	16342
such signals were maintained up to 2	16342
such signals	16342
2	16377
3 months -LRB- Fig. 2A -RRB-	16379
Fig. 2A	16389
contrast	16402
dead OEC	16420
2 mm of the injection site	16455
2 mm	16455
the injection site	16463
4 weeks	16488
deposition in the cord -LRB- Fig. 2B -RRB-	16502
deposition	16502
the cord -LRB- Fig. 2B -RRB-	16516
the cord	16516
Fig. 2B	16526
The injection of unlabeled live OEC	16536
The injection	16536
unlabeled live OEC	16553
no MRI contrast change	16589
a minor contrast change	16618
it	16655
a tiny spot which was clearly less marked than that caused by MD-100	16672
a tiny spot	16672
that caused by MD-100	16719
that	16719
MD-100	16734
We	16742
this minimal contrast change at the injection site of unlabeled cells	16758
this minimal contrast change	16758
the injection site of unlabeled cells	16790
the injection site	16790
unlabeled cells	16812
mild hemorrhage	16844
Fig. 2C	16861
The MRI findings	16871
that obtained using histological staining for iron -LRB- DAB-enhanced Prussian blue stain , Pearson correlation coefficient 0.694 ; P < 0.05 -RRB- and grafted OEC -LRB- p75-immunoreactive , Pearson correlation coefficient 0.802 ; P < 0.01 -RRB-	16917
that	16917
histological staining	16937
iron -LRB- DAB-enhanced Prussian blue stain , Pearson correlation coefficient 0.694 ; P < 0.05 -RRB- and grafted OEC -LRB- p75-immunoreactive , Pearson correlation coefficient 0.802 ; P < 0.01 -RRB-	16963
iron -LRB- DAB-enhanced Prussian blue stain , Pearson correlation coefficient 0.694 ; P < 0.05 -RRB-	16963
iron	16963
DAB-enhanced Prussian blue stain , Pearson correlation coefficient 0.694 ; P < 0.05	16969
DAB-enhanced Prussian blue stain	16969
DAB-enhanced	16969
Prussian blue	16982
Pearson correlation coefficient 0.694	17003
Pearson correlation coefficient	17003
0.694	17035
P < 0.05	17042
P <	17042
P	17042
0.05	17046
grafted OEC -LRB- p75-immunoreactive , Pearson correlation coefficient 0.802 ; P < 0.01 -RRB-	17056
grafted OEC	17056
p75-immunoreactive , Pearson correlation coefficient 0.802 ; P < 0.01	17069
p75-immunoreactive , Pearson correlation coefficient 0.802 ; P <	17069
p75-immunoreactive , Pearson correlation coefficient 0.802	17069
p75-immunoreactive , Pearson correlation	17069
coefficient 0.802	17109
P <	17128
P	17128
<	17130
0.01	17132
DAB-enhanced Prussian blue stain	17139
DAB-enhanced	17139
Prussian blue	17152
bipolar or round brownish cells	17179
dark iron granules	17222
The labeled cells	17242
the dorsal column	17290
gray matter	17331
the area of MRI contrast signals -LRB- Fig. 2D -RRB-	17355
the area	17355
MRI contrast signals -LRB- Fig. 2D -RRB-	17367
MRI contrast signals	17367
Fig. 2D	17389
the p75 immunoreactivity	17405
densely packed bipolar cells	17431
the host	17487
spinal cord tracts -LRB- maximal extension found : 8 mm at 8 weeks postgrafting , Fig. 2E -RRB-	17496
spinal cord tracts	17496
maximal extension found : 8 mm at 8 weeks postgrafting , Fig. 2E	17516
maximal extension	17516
8 mm at 8 weeks postgrafting , Fig. 2E	17541
8 mm	17541
8 weeks postgrafting , Fig. 2E	17549
8 weeks postgrafting	17549
8 weeks	17549
Fig. 2E	17571
dead cells	17589
little iron	17605
no p75 immunoreactivity at infusion sites	17627
no p75 immunoreactivity	17627
infusion sites	17654
4 weeks	17675
This	17684
iron particles from	17703
iron particles	17703
transplanted cells are biodegraded -LRB- cleared away -RRB- rather than taken up by surrounding cells at 4 weeks	17735
transplanted cells	17735
surrounding cells	17809
4 weeks	17830
The two histological markers , p75 and DAB-enhanced Prussian blue ,	17852
The two histological markers	17852
p75 and DAB-enhanced Prussian blue	17882
p75	17882
DAB-enhanced Prussian blue	17890
each other as well -LRB- Pearson correlation coefficient 0.826 ; P < 0.01 -RRB-	17937
each other as well	17937
Pearson correlation coefficient 0.826 ; P < 0.01	17957
Pearson correlation coefficient 0.826 ; P <	17957
Pearson correlation coefficient 0.826	17957
Pearson correlation coefficient	17957
0.826	17989
P <	17996
P	17996
<	17998
0.01	18000
Limited OEC migration in the transected spinal cord When MD-100 labeled OEC were injected into the transected spinal cord , the injection site	18007
Limited OEC migration	18007
the transected spinal cord When MD-100 labeled OEC were injected into the transected spinal cord , the injection site	18032
the transected spinal cord	18032
MD-100 labeled OEC	18064
MD-100	18064
OEC	18079
the transected spinal cord , the injection site	18102
the transected spinal cord	18102
the injection site	18130
a dark area due to the pronounced loss of MRI signal	18182
a dark area	18182
the pronounced loss of MRI signal	18201
the pronounced loss	18201
MRI signal	18224
visible changes of hypointense MRI contrast patterns	18261
visible changes	18261
hypointense MRI contrast patterns	18280
stumps of the transected cord at 1 week postgrafting	18343
stumps	18343
the transected cord at 1 week postgrafting	18353
the	18353
cord	18368
1 week postgrafting	18376
This	18397
whether	18420
cells	18436
the rostral or caudal stump	18464
the rostral	18464
caudal stump	18479
Parallel to the extended MRI contrast within the injected stump , the contrast in the noninjected stump also became elongated -LRB- maximum of 22 mm at 8 weeks postgrafting -RRB- -LRB- Fig. 3A -RRB- .	18493
Parallel	18493
the extended MRI contrast within the injected stump , the contrast in the noninjected stump also became elongated -LRB- maximum of 22 mm at 8 weeks postgrafting -RRB- -LRB- Fig. 3A -RRB-	18505
the extended MRI contrast within the injected stump , the contrast in the noninjected stump also became elongated -LRB- maximum of 22 mm at 8 weeks postgrafting -RRB-	18505
the extended MRI contrast within the injected stump , the contrast in the noninjected stump also became elongated	18505
the extended MRI contrast	18505
the injected stump , the contrast in the noninjected stump also became elongated	18538
the injected stump	18538
the contrast in the noninjected stump	18558
the contrast	18558
the noninjected stump	18574
maximum of 22 mm at 8 weeks postgrafting	18619
maximum	18619
22 mm at 8 weeks postgrafting	18630
22 mm	18630
8 weeks postgrafting	18639
8 weeks	18639
Fig. 3A	18662
the cause of the contrast changes	18684
the cause	18684
the contrast changes	18697
the noninjected stump	18721
we	18744
DAB-enhanced Prussian	18757
postmortem	18790
a large number of cells with DAB reaction product	18816
a large number	18816
cells with DAB reaction product	18834
cells	18834
DAB reaction product	18845
the white matter tracts in both stumps -LRB- Fig. 3B -RRB-	18885
the white matter tracts	18885
both stumps -LRB- Fig. 3B -RRB-	18912
both stumps	18912
Fig. 3B	18925
such stained cells	18948
such	18948
cells	18961
the control transected cord given only medium injection -LRB- data not shown -RRB-	18988
the control	18988
cord	19011
only medium injection -LRB- data not shown -RRB-	19022
only medium injection	19022
data not shown	19045
data	19045
These cells	19062
data not shown	19104
data	19104
they	19137
microglia/macrophages	19157
It	19180
spinal cord transection	19208
reactive microglia/macrophages accumulated endogenous hemorrhage -LRB- hemosiderin -RRB- products as well as possibly phagocytized exogenous MD - 100 labeled OEC	19233
reactive microglia/macrophages	19233
endogenous hemorrhage -LRB- hemosiderin -RRB- products	19276
hemosiderin	19299
exogenous MD - 100 labeled	19354
exogenous MD	19354
100 labeled	19368
100	19368
OEC	19380
The two compartments of ferric ions -LRB- MD-100 and hemosiderin products -RRB- could not be clearly distinguished by Prussian blue	19385
The two compartments	19385
ferric ions -LRB- MD-100 and hemosiderin products -RRB- could not be clearly distinguished by Prussian blue	19409
ferric ions	19409
MD-100 and hemosiderin products	19422
Prussian blue	19493
MRI	19525
We	19530
these microglia/macrophages	19546
MRI	19591
they	19601
hemorrhage -LRB- hemosiderin -RRB- products	19622
hemorrhage	19622
hemosiderin	19634
MD-100 released by dead OEC -LRB- for the injected stump -RRB-	19672
MD-100	19672
dead OEC -LRB- for the injected stump -RRB-	19691
the injected stump	19705
Prussian blue	19740
the MRI contrast in the stump of transplantation -LRB- Pearson correlation coefficient 0.628 , P < 0.05 , Fig. 3C -RRB-	19778
the MRI contrast	19778
the stump of transplantation -LRB- Pearson correlation coefficient 0.628 , P < 0.05 , Fig. 3C -RRB-	19798
the stump	19798
transplantation -LRB- Pearson correlation coefficient 0.628 , P < 0.05 , Fig. 3C -RRB-	19811
transplantation	19811
Pearson correlation	19828
coefficient 0.628 , P < 0.05 , Fig. 3C	19848
coefficient 0.628	19848
P < 0.05	19867
P <	19867
P	19867
0.05	19871
Fig. 3C	19877
the noninjected stump -LRB- Fig. 3D -RRB-	19898
the noninjected stump	19898
Fig. 3D	19921
The p75 immunoreactivity	19931
fewer OEC	19968
the transected spinal cord	19990
the normal spinal cord	20025
the cell number	20053
2 months postgrafting	20106
2 months	20106
p75-positive OEC	20129
limited migration	20153
the stump of transplantation	20174
the stump	20174
transplantation	20187
maximal 4.1 mm	20204
8 weeks postgrafting	20231
8 weeks	20231
significant change of distance between 1 and 8 weeks postgrafting	20261
significant change	20261
distance between 1 and 8 weeks postgrafting	20283
distance	20283
1 and 8 weeks postgrafting	20300
1 and 8 weeks	20300
Neurofilament-positive fibers	20328
the OEC transplant area parallel	20372
its long axis -LRB- Fig. 3E -RRB-	20408
its long axis	20408
Fig. 3E	20423
The grafts	20433
GFAP-negative following transplantation and somewhat intermingled with GFAP-positive fibers at the host -- graft borders	20449
GFAP-negative following transplantation	20449
somewhat intermingled with GFAP-positive fibers at the host -- graft borders	20493
GFAP-positive fibers at the host -- graft	20520
GFAP-positive fibers	20520
the host -- graft	20544
grafted cells	20581
the transection gap	20611
there	20635
no p75-immunoreactive cells in the opposite stump 8 weeks postgrafting -LRB- Fig. 3F -RRB-	20646
no p75-immunoreactive cells	20646
the opposite stump 8 weeks postgrafting	20677
the opposite stump	20677
8 weeks	20696
Fig. 3F	20718
This	20728
the control transected cord with delivery of unlabeled OEC , indicating that the migratory ability of OEC was not limited by iron loading	20754
the control	20754
cord	20777
delivery of unlabeled OEC	20787
delivery	20787
unlabeled OEC	20799
the migratory ability of OEC	20830
the migratory ability	20830
OEC	20855
iron loading	20878
Behavioral results BBB scores	20892
Behavioral results	20892
BBB scores	20911
every 2 weeks up to 8 weeks postgrafting	20936
every 2 weeks up to 8 weeks	20936
2 weeks	20942
No significant improvements of BBB scores	20978
No significant improvements	20978
BBB scores	21009
animals with control transected cords , medium injection , or OEC-treated transected cords	21034
animals	21034
control transected cords , medium injection , or OEC-treated transected cords	21047
control transected cords	21047
medium injection	21073
OEC-treated transected cords	21094
Discussion	21125
we	21142
tracking	21161
a prolonged period of time of OEC grafted into normal and transected spinal cords	21174
a prolonged period	21174
time of OEC grafted into normal and transected spinal cords	21196
time	21196
OEC grafted into normal and transected spinal cords	21204
OEC	21204
normal and transected spinal cords	21221
OEC	21278
a complete transection of the spinal cord	21304
a complete transection	21304
the spinal cord	21330
The use of iron nanoparticles for labeling cells and their in vivo MRI detection	21347
The use	21347
iron nanoparticles for labeling cells and their in vivo MRI detection	21358
iron nanoparticles for labeling cells	21358
iron nanoparticles	21358
labeling cells	21381
their in vivo MRI detection	21400
their in vivo	21400
their	21400
vivo	21409
MRI detection	21414
Hawrylak et al. , 1993 ; Norman et al. , 1992	21458
Hawrylak	21458
et al. , 1993 ; Norman et al. , 1992	21467
et al. , 1993	21467
et al.	21467
1993	21475
Norman et al. , 1992	21481
Norman	21481
et al. , 1992	21488
et al.	21488
1992	21496
Early studies	21503
particles in the micrometer range which could overload cells to be grafted and decrease their mobility -LRB- Norman et al. , 1992 -RRB-	21522
particles	21522
the micrometer range which could overload cells to be grafted and decrease their mobility -LRB- Norman et al. , 1992 -RRB-	21535
the micrometer range	21535
overload cells	21568
their mobility	21610
Norman	21626
et al. , 1992	21633
et al.	21633
1992	21641
the size of labeling particles has been reduced to the nanometer range with only minimal effects on cell function and at the same time	21658
the size	21658
particles	21679
the nanometer range with only minimal effects on cell function	21709
the nanometer range	21709
only minimal effects on cell function	21734
only minimal effects	21734
cell function	21758
the same time	21779
effects	21803
MRI contrast	21814
the incorporation of superparamagnetic compounds	21830
the incorporation	21830
superparamagnetic compounds	21851
cells	21888
MR imaging of excised tissue ex vivo allowing prolonged measurements needed to achieve high resolution and acceptable	21916
MR imaging	21916
tissue ex vivo	21938
prolonged measurements needed to achieve high resolution	21962
prolonged measurements	21962
high resolution	22003
signal-to noise ratios -LRB- Bulte et al. , 1999 ; Franklin et al. , 1999 -RRB-	22034
signal-to noise ratios	22034
Bulte	22058
et al. , 1999 ; Franklin et al. , 1999	22064
et al.	22064
1999 ; Franklin et al.	22072
1999	22072
Franklin et al.	22078
Franklin	22078
et al.	22087
1999	22095
We	22102
dendrimer-coated MD-100 iron oxide particles which are effectively endocytosed nonspecifically and accumulate in cytoplasmic endosomes -LRB- Bulte et al. , 2001 -RRB-	22110
dendrimer-coated MD-100 iron oxide particles	22110
cytoplasmic endosomes -LRB- Bulte et al. , 2001 -RRB-	22223
cytoplasmic endosomes	22223
Bulte	22246
et al. , 2001	22252
et al.	22252
2001	22260
The labeling procedure	22267
The high contrast effects on MRI contrast	22312
The high contrast effects	22312
MRI contrast	22341
an experimental time frame of about 1 -- 2 h per animal , which is ideal for short and repetitive in vivo MRI	22380
an experimental time frame of about 1 -- 2 h per animal	22380
an experimental time frame of about 1	22380
an experimental time frame	22380
1	22416
2 h per animal	22418
2 h	22418
animal	22426
MRI	22482
the transected cord with either medium injection or an OEC graft	22490
the	22490
cord	22505
either medium injection or an OEC graft	22515
medium injection	22522
an OEC graft	22542
hemorrhage products	22556
rise	22581
extensive Prussian blue deposits	22589
we	22627
iron-containing nanoparticles	22657
The hemorrhage degradation products	22688
macrophages	22744
macrophages	22764
the major cellular pathway for redistribution of iron in mammals	22787
the major cellular pathway	22787
redistribution of iron in mammals	22818
redistribution	22818
iron in mammals	22836
iron	22836
mammals	22844
the hemorrhage	22866
T2-weighted hypointensity , the degree of which depended on the degree of surgical damage	22893
T2-weighted hypointensity	22893
the degree	22920
the degree of surgical damage	22952
the degree	22952
surgical damage	22966
This	22983
the detection of labeled cells	23004
the detection	23004
labeled cells	23021
the interpretation of MR imaging	23051
the interpretation	23051
MR imaging	23073
the hypointense contrast	23091
the injected and noninjected stump	23137
the live labeled cell injections	23176
cells	23214
the transection zone	23244
the hypointense contrast in the noninjected stump	23266
the hypointense contrast	23266
the noninjected stump	23294
hemorrhage	23339
the injected stump	23354
the MR contrast	23383
DAB-enhanced Prussian blue staining , which is presumably a combination of nanoparticles and hemorrhage	23429
DAB-enhanced Prussian blue staining	23429
a combination of nanoparticles and hemorrhage	23486
a combination	23486
nanoparticles and hemorrhage	23503
A quantitative mismatch between the distributions of MR contrast and histological markers	23533
A quantitative mismatch	23533
the distributions of MR contrast and histological markers	23565
the distributions	23565
MR contrast and histological markers	23586
MR contrast	23586
histological markers	23602
redistribution of nanoparticles	23642
redistribution	23642
nanoparticles	23660
example	23679
macrophages -LRB- Cadusseau and Peschanski , 1989 ; Hawrylak et al. , 1993 -RRB-	23691
macrophages	23691
Cadusseau and Peschanski , 1989 ; Hawrylak et al. , 1993	23704
Cadusseau and Peschanski	23704
1989 ; Hawrylak et al.	23730
1989	23730
Hawrylak et al.	23736
Hawrylak	23736
et al.	23745
1993	23753
Severe injuries	23760
massive inflammatory infiltration	23786
metabolism of the biodegradable iron particles	23835
metabolism	23835
the biodegradable iron particles	23849
it	23894
cell labels	23931
cell transplants	23967
pathological conditions	24001
The migratory ability of OEC confronted with glial scar in vivo	24026
The migratory ability	24026
OEC confronted with glial scar in vivo	24051
OEC	24051
glial scar in vivo	24071
glial scar	24071
vivo	24085
OEC	24112
more	24138
Schwann cells in an astrocytic environment -LRB- Lakatos et al. , 2000 -RRB-	24160
Schwann cells	24160
an astrocytic environment -LRB- Lakatos et al. , 2000 -RRB-	24177
an astrocytic environment	24177
Lakatos	24204
et al. , 2000	24212
et al.	24212
2000	24220
This property	24227
an advantage for transplant-mediated repair	24253
an advantage	24253
transplant-mediated repair	24270
the damaged CNS , where OEC may both guide and remyelinate regenerating axons	24300
the damaged CNS	24300
OEC	24323
both guide and remyelinate	24331
axons	24371
a scaffold of hospitable environment	24388
a scaffold	24388
hospitable environment	24402
Some reports	24426
OEC , labeled by Hoechst 33342 ,	24459
OEC	24459
Hoechst 33342	24475
glial scars in injured spinal cords -LRB- Boruch et al. , 2001 ; Ramon-Cueto et al. , 1998 , 2000 -RRB-	24531
glial scars	24531
injured spinal cords -LRB- Boruch et al. , 2001 ; Ramon-Cueto et al. , 1998 , 2000 -RRB-	24546
injured spinal cords	24546
Boruch et al. , 2001 ; Ramon-Cueto et al. , 1998 , 2000	24568
Boruch et al.	24568
Boruch	24568
et al.	24575
2001 ; Ramon-Cueto et al.	24583
2001	24583
Ramon-Cueto et al.	24589
Ramon-Cueto	24589
et al.	24601
1998 , 2000	24609
1998	24609
2000	24615
the Hoechst label	24631
host cells	24676
macrophages , nuclei in white matter , ependymal cells , endothelial cells , and meningeal cells	24698
macrophages	24698
nuclei in white matter	24711
nuclei	24711
white matter	24721
ependymal cells	24735
endothelial cells	24752
meningeal cells	24775
2 h	24803
grafting -LRB- Iwashita et al. , 2000 -RRB-	24813
grafting	24813
Iwashita	24823
et al. , 2000	24832
et al.	24832
2000	24840
migratory behavior of OEC	24853
migratory behavior	24853
OEC	24875
the Hoechst label	24910
Ruitenberg et al. -LRB- 2002 -RRB-	24929
Ruitenberg et al.	24929
Ruitenberg	24929
et al.	24940
2002	24948
a unilateral dorsolateral funiculus lesion of the spinal cord	24972
a unilateral dorsolateral funiculus lesion	24972
the spinal cord	25018
OEC identified by the endogenous marker p75 and by lentiviral-transferred green fluorescent protein	25035
OEC	25035
the endogenous marker p75	25053
lentiviral-transferred green fluorescent protein	25086
only limited migration	25145
the lesion	25173
the astrocytic barrier	25210
times up to 4 months postgrafting	25236
times up to 4 months	25236
times	25236
the other hand	25274
normal adult rat brains	25293
OEC labeled with PKH-26	25318
OEC	25318
PKH-26	25335
1 month postgrafting -LRB- Gudino-Cabrera and Nieto-Sampedro , 1996 -RRB- , and in a localized corticospinal tract -LRB- CST -RRB- lesion in the spinal cord , OEC identified by the endogenous markers p75 and P0	25374
1 month postgrafting	25374
Gudino-Cabrera and Nieto-Sampedro , 1996	25396
Gudino-Cabrera and Nieto-Sampedro	25396
1996	25431
a localized corticospinal tract -LRB- CST -RRB- lesion	25445
CST	25478
the spinal cord	25493
OEC identified by the endogenous markers p75 and P0	25510
OEC	25510
the endogenous markers p75 and P0	25528
more than 10 mm within the boundary of the host CST at 3 months postgrafting -LRB- Li et al. , 1998 -RRB-	25579
more than 10 mm	25579
the boundary of the host CST at 3 months postgrafting	25602
the boundary	25602
the host CST at 3 months postgrafting	25618
the host CST	25618
3 months postgrafting	25634
3 months	25634
Li	25657
et al. , 1998	25660
et al.	25660
1998	25668
Our results	25675
an extensive migratory behavior of OEC in normal spinal cords	25695
an extensive migratory behavior	25695
OEC in normal spinal cords	25730
OEC	25730
normal spinal cords	25737
transected cords	25772
OEC	25795
a limited distance	25812
injection sites	25836
a complete spinal cord injury zone	25875
We	25911
the mobility of OEC	25937
the mobility	25937
OEC	25953
the kind and degree of CNS injury	25971
the kind and degree	25971
CNS injury	25994
OEC	26006
a relatively circumscribed lesion but not a complete transection gap	26023
a relatively circumscribed lesion	26023
a complete transection gap	26065
proper attention to the confounding factor of hemorrhage	26098
proper attention	26098
the confounding factor of hemorrhage	26118
the confounding factor	26118
hemorrhage	26144
superparamagnetic nanoparticles	26176
an additional tool alongside previous cell markers	26223
an additional tool	26223
previous cell markers	26252
these nanoparticles	26282
us	26309
cell survival and migration	26323
spatial and temporal resolution in the living animal	26370
spatial and temporal resolution	26370
the living animal	26405
